Safety of a Novel Weight Loss Combination Product Containing Orlistat and Acarbose

The safety of a novel modified‐release oral capsule with orlistat and acarbose (MR‐OA) was investigated in 67 obese middle‐aged White men with a body mass index of 32 to 40 kg/m(2) or 30 to 32 kg/m(2) plus waist circumference >102 cm. The purpose of this investigation was to compare MR‐OA with th...

Descripción completa

Detalles Bibliográficos
Autores principales: Grudén, Stefan, Forslund, Anders, Alderborn, Göran, Söderhäll, Arvid, Hellström, Per M., Holmbäck, Ulf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518499/
https://www.ncbi.nlm.nih.gov/pubmed/33580745
http://dx.doi.org/10.1002/cpdd.920

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518499/
https://www.ncbi.nlm.nih.gov/pubmed/33580745
http://dx.doi.org/10.1002/cpdd.920

Ejemplares similares